It was a poorly written article and picked the wrong drug to use as an example of price gouging. 1 - there are other alternatives available and 2 - Pernix offers HEAVY discounts if you go direct and the spokesperson for Pernix even said "if the customer calls direct, they can get the prescription pack filled at $20". Pernix is no KBIO, where KBIO had the only solution for some and they forced price hikes because they were the only drug available. That's wrong. WSJ made a poor decision on who they targeted.
